We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Medtronic

Medtronic offers medical products and therapies for the treatment of cardiac and vascular diseases, diabetes, and neu... read more Featured Products: More products

Download Mobile App




World's First and Only Infusion Set for Insulin Pumps Doubles Wear Time up to Seven Days

By HospiMedica International staff writers
Posted on 21 Nov 2022
Print article
Image: The Extended infusion set provides annual costs savings of insulin of up to 25% and reduces plastic waste by up to 50% (Photo courtesy of Medtronic)
Image: The Extended infusion set provides annual costs savings of insulin of up to 25% and reduces plastic waste by up to 50% (Photo courtesy of Medtronic)

An infusion set is tubing that delivers insulin from an insulin pump to the body and typically requires a set change every two to three days. Now, the world’s first and only infusion set labeled for up to seven-day wear has been launched in the U.S.

Medtronic plc (Dublin, Ireland) has announced the U.S. launch of Medtronic Extended infusion set which has been developed in partnership with Convatec Infusion Care (Oklahoma City, OK, USA) and is the world’s first and only infusion set labeled for up to seven-day wear. The Medtronic Extended infusion set uses advanced materials that help reduce insulin preservative loss and maintain insulin flow and stability to double the wear time of an infusion set. Its innovative design leverages proprietary technology, including a new tubing connector that improves physical and chemical stability of insulin, the reliability of infusion site performance, and reduces the risk of infusion set occlusion. The adhesive patch also has an adhesive layer that helps extend wear time and provides comfort and durability for up to seven days. In addition to the new infusion set, the Medtronic Extended reservoir is the only infusion set reservoir tested and cleared to help keep insulin stable and safe to use for up to seven days.

In clinical studies of the Medtronic Extended infusion set, study participants observed a decrease in the number of times an infusion set needed to be changed by 50% and the number of infusion set failures associated with high glucose levels was lowered. Study participants commented on the new infusion set being more comfortable to wear compared to their previous infusion sets and were happy with the longer wear feature in helping reduce the overall burden of insulin pump therapy. Additionally, use of the Medtronic Extended infusion set is estimated to result in annual costs savings of insulin of up to 25% due to a reduced number of infusion set and reservoir changes that result in unrecoverable insulin, as well as plastic waste reduction of up to 50%. With the U.S. launch of the Medtronic Extended infusion set, this innovation is now available exclusively for customers using MiniMed 600 and 700 series pumps.

"When patients first begin using a pump, doctors and other healthcare providers reinforce the need to change their infusion set every two to three days to limit the risk of infection and other safety concerns. For many people, this means scheduling life around infusion set changes, which may not be at the most convenient times - turning around as you are headed out the door when you suddenly remember to change your infusion set or adding a few minutes to a tired child's bedtime routine with an infusion set change," said Dr. Robert Vigersky, Chief Medical Officer, Medtronic Diabetes. "With the Medtronic Extended infusion set, these life interruptions are reduced with an innovation that doubles the wear."

"Our goal is to make life easier for individuals living with diabetes and the Medtronic Extended infusion set helps us deliver on this with prolonged and more comfortable wear – something customers have been requesting for many years," said Que Dallara, EVP & President, Medtronic Diabetes. "We couldn't be more pleased to launch this innovation during Diabetes Awareness Month when we take the time to reflect on what more we can do to alleviate the burden for those living with this chronic condition. We're pleased to deliver a groundbreaking innovation that will make a real difference in the overall pump experience given the overwhelming and well-documented benefits of this therapeutic option."

Related Links:
Medtronic plc
Convatec Infusion Care

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Information Management System
Innovian Anesthesia

Print article

Channels

Surgical Techniques

view channel
Image: The Early Bird Bleed Monitoring System provides visual and audible indicators of the onset and progression of bleeding events (Photo courtesy of Saranas)

Novel Technology Monitors and Lowers Bleeding Complications in Patients Undergoing Heart Procedures

Bleeding complications at the femoral access site can significantly hamper recovery, affecting the success of procedures, patient satisfaction, and overall healthcare costs. It is crucial for surgeons... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.